- Tremor in Parkinson's disease and serotonergic dysfunction: an 11C-WAY 100635 PET studyM Doder
Division of Neuroscience and MRC Clinical Sciences Centre, Faculty of Medicine, Imperial College, London, UK
Neurology 60:601-5. 2003..With PET, the aim of this study was to examine regional cerebral (11)C-WAY 100635 binding to 5-HT(1A) receptors in patients with PD and to correlate it with severity of tremor...
- Positron emission tomography analysis of [11C]KW-6002 binding to human and rat adenosine A2A receptors in the brainD J Brooks
MRC Clinical Sciences Centre and Division of Neuroscience, Faculty of Medicine, Imperial College, London, United Kingdom
Synapse 62:671-81. 2008..MRS 1745, an A(2B) receptor selective antagonist, had no effect on the cerebellar binding of [(11)C]KW-6002 in rats, suggesting that this blockable signal is unlikely to result from an affinity for adenosine A(2B) receptors...
- Randomized trial of tolcapone versus pergolide as add-on to levodopa therapy in Parkinson's disease patients with motor fluctuationsW Koller
University of Miami, Miami, Florida, USA
Mov Disord 16:858-66. 2001..Tolcapone provided greater improvements in quality of fife, was better tolerated, and had a more favorable adverse-event profile than pergolide...